{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:21:26Z","timestamp":1791116486587,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.037","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T09:20:34Z","timestamp":1293787234000},"page":"1690-1699","source":"Crossref","is-referenced-by-count":28,"title":["Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV)"],"prefix":"10.1016","volume":"29","author":[{"given":"Isaac","family":"Sipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Knauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Poller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Planz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Norley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.12.037_bib0005","first-page":"291","article-title":"Pandemic influenza vaccines","volume":"333","author":"DiMenna","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nm0695-583","article-title":"Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus","volume":"1","author":"Donnelly","year":"1995","journal-title":"Nat Med"},{"issue":"December (16)","key":"10.1016\/j.vaccine.2010.12.037_bib0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0264-410X(94)90081-7","article-title":"Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines","volume":"12","author":"Ulmer","year":"1994","journal-title":"Vaccine"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2010.12.037_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/dna.1993.12.777","article-title":"Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors","volume":"12","author":"Montgomery","year":"1993","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2010.12.037_bib0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2334-7-118","article-title":"Vaccination with hemagglutinin or neuraminidase DNA protects BALB\/c mice against influenza virus infection in presence of maternal antibody","volume":"7","author":"Chen","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.4.6.6177","article-title":"Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A\/H5N1","volume":"4","author":"Kendirgi","year":"2008","journal-title":"Hum Vaccin"},{"issue":"February 1(3)","key":"10.1016\/j.vaccine.2010.12.037_bib0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/595984","article-title":"Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques","volume":"199","author":"Kreijtz","year":"2009","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.12.037_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/erv.09.1","article-title":"Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines","volume":"8","author":"Tang","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"September 28 (39\u201340)","key":"10.1016\/j.vaccine.2010.12.037_bib0045","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2007.07.035","article-title":"Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein","volume":"25","author":"Roy","year":"2007","journal-title":"Vaccine"},{"issue":"June 10 (9)","key":"10.1016\/j.vaccine.2010.12.037_bib0050","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/104303401750214276","article-title":"A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus","volume":"12","author":"Xin","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2010.12.037_bib0055","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1128\/JVI.01441-09","article-title":"A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque","volume":"83","author":"Lin","year":"2009","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.037_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bies.950170310","article-title":"The cryptic life style of adeno-associated virus","volume":"17","author":"Berns","year":"1995","journal-title":"Bioessays"},{"issue":"July 20 (15)","key":"10.1016\/j.vaccine.2010.12.037_bib0065","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1073\/pnas.96.15.8657","article-title":"Long-term regulated expression of growth hormone in mice after intramuscular gene transfer","volume":"96","author":"Rivera","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"June 1 (11)","key":"10.1016\/j.vaccine.2010.12.037_bib0070","first-page":"3077","article-title":"rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice","volume":"62","author":"Davidoff","year":"2002","journal-title":"Cancer Res"},{"issue":"November 15 (22)","key":"10.1016\/j.vaccine.2010.12.037_bib0075","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.037_bib0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"issue":"July 20 (11)","key":"10.1016\/j.vaccine.2010.12.037_bib0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/104303403322124792","article-title":"Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study","volume":"14","author":"Flotte","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"April 15 (8)","key":"10.1016\/j.vaccine.2010.12.037_bib0090","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood.V99.8.2670","article-title":"Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy","volume":"99","author":"Mount","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.12.037_bib0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/0470092645.ch15","article-title":"Gene therapy for Leber congenital amaurosis","volume":"255","author":"Bennett","year":"2004","journal-title":"Novartis Found Symp"},{"issue":"August 10 (12)","key":"10.1016\/j.vaccine.2010.12.037_bib0100","first-page":"1589","article-title":"Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation","volume":"12","author":"During","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.12.037_bib0105","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.1967","article-title":"Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys","volume":"15","author":"Johnson","year":"2009","journal-title":"Nat Med"},{"issue":"July (Pt. 7)","key":"10.1016\/j.vaccine.2010.12.037_bib0110","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1099\/0022-1317-72-7-1551","article-title":"Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics","volume":"72","author":"Southern","year":"1991","journal-title":"J Gen Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.037_bib0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00109-008-0363-x","article-title":"Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy","volume":"86","author":"Fechner","year":"2008","journal-title":"J Mol Med"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2010.12.037_bib0120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.gt.3302987","article-title":"Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction","volume":"14","author":"Sipo","year":"2007","journal-title":"Gene Ther"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.12.037_bib0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.1995.tb03662.x","article-title":"Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7","volume":"42","author":"Bauer","year":"1995","journal-title":"Scand J Immunol"},{"issue":"March 28 (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(86)90019-X","article-title":"The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides","volume":"44","author":"Townsend","year":"1986","journal-title":"Cell"},{"issue":"June 14 (27)","key":"10.1016\/j.vaccine.2010.12.037_bib0135","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/S0264-410X(01)00078-0","article-title":"Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene","volume":"19","author":"Okuda","year":"2001","journal-title":"Vaccine"},{"issue":"March 3 (5597)","key":"10.1016\/j.vaccine.2010.12.037_bib0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/266052a0","article-title":"Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells","volume":"266","author":"Virelizier","year":"1977","journal-title":"Nature"},{"issue":"March 19 (5102)","key":"10.1016\/j.vaccine.2010.12.037_bib0145","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"issue":"June 23 (9579)","key":"10.1016\/j.vaccine.2010.12.037_bib0150","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"issue":"February (2 Pt 1)","key":"10.1016\/j.vaccine.2010.12.037_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005537-199902000-00017","article-title":"Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus","volume":"109","author":"Wagner","year":"1999","journal-title":"Laryngoscope"},{"issue":"July 1 (1)","key":"10.1016\/j.vaccine.2010.12.037_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2005-12-5115","article-title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0165","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.77.6.3495-3504.2003","article-title":"Genetic fate of recombinant adeno-associated virus vector genomes in muscle","volume":"77","author":"Schnepp","year":"2003","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.037_bib0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/hum.2005.16.541","article-title":"Adeno-associated virus vectors in clinical trials","volume":"16","author":"Carter","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.12.037_bib0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1743-422X-4-99","article-title":"The state of the art of adeno-associated virus-based vectors in gene therapy","volume":"4","author":"Coura Rdos","year":"2007","journal-title":"Virol J"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2010.12.037_bib0180","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1128\/JVI.01253-07","article-title":"Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice","volume":"81","author":"Lin","year":"2007","journal-title":"J Virol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.12.037_bib0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/JVI.79.2.955-965.2005","article-title":"Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques","volume":"79","author":"Johnson","year":"2005","journal-title":"J Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.037_bib0190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1089\/hum.2009.060","article-title":"Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses","volume":"20","author":"Gao","year":"2009","journal-title":"Hum Gene Ther"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0195","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/aid.2007.0292","article-title":"A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine","volume":"24","author":"Mehendale","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.037_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/biot.200900267","article-title":"Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB\/c mice","volume":"5","author":"Krammer","year":"2010","journal-title":"Biotechnol J"},{"issue":"June (5)","key":"10.1016\/j.vaccine.2010.12.037_bib0205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.12.037_bib0210","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1128\/JVI.00101-10","article-title":"Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu","volume":"84","author":"Solorzano","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.037_bib0215","doi-asserted-by":"crossref","first-page":"e10492","DOI":"10.1371\/journal.pone.0010492","article-title":"A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice","volume":"5","author":"Steitz","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2010.12.037_bib0220","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1371\/journal.pone.0001190","article-title":"Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets","volume":"2","author":"Heiny","year":"2007","journal-title":"PLoS One"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2010.12.037_bib0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1750-2659.2007.00010.x","article-title":"Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1","volume":"1","author":"Zhirnov","year":"2007","journal-title":"Influenza Other Respi Viruses"},{"issue":"November 16 (46\u201347)","key":"10.1016\/j.vaccine.2010.12.037_bib0230","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.037_bib0235","doi-asserted-by":"crossref","first-page":"e2432","DOI":"10.1371\/journal.pone.0002432","article-title":"Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice","volume":"3","author":"Rao","year":"2008","journal-title":"PLoS One"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.12.037_bib0240","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"issue":"May 22 (11)","key":"10.1016\/j.vaccine.2010.12.037_bib0245","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1073\/pnas.101132698","article-title":"Measuring the diaspora for virus-specific CD8+ T cells","volume":"98","author":"Marshall","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.037_bib0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1201.051237","article-title":"Cell-mediated protection in influenza infection","volume":"12","author":"Thomas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.12.037_bib0255","first-page":"3958","article-title":"Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice","volume":"117","author":"Lin","year":"2007","journal-title":"J Clin Invest"},{"issue":"September 15 (6)","key":"10.1016\/j.vaccine.2010.12.037_bib0260","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"issue":"February (Pt. 2)","key":"10.1016\/j.vaccine.2010.12.037_bib0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-68-2-433","article-title":"Purified influenza virus nucleoprotein protects mice from lethal infection","volume":"68","author":"Wraith","year":"1987","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T12:47:45Z","timestamp":1559911665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10018104"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}